The Dutch Early-Stage Melanoma Study (D-ESMEL): a Discovery Set and Validation Cohort to Predict the Absolute Risk of Distant Metastases in Stage I/II Cutaneous Melanoma

• C. Zhou,
• A. Mooyaart,
• T. Kerkour,
• M. Louwman,
• M. Wakkee,
• R. Voorham,
• A. Gijsbers-Bruggink,
• T. Nijsten,
• L. Hollestein

Affiliations

C. Zhou

Erasmus MC Cancer Institute, Dermatology, Rotterdam, The Netherlands

A. Mooyaart

Erasmus MC Cancer Institute, Pathology, Rotterdam, The Netherlands

T. Kerkour

Erasmus MC Cancer Institute, Dermatology, Rotterdam, The Netherlands

M. Louwman

Netherlands Comprehensive Cancer Organization, Research and Development, Utrecht, The Netherlands

M. Wakkee

Erasmus MC Cancer Institute, Dermatology, Rotterdam, The Netherlands

R. Voorham

Nationwide Network and Registry of Histo- and Cytopathology, Houten, The Netherlands

A. Gijsbers-Bruggink

Nationwide Network and Registry of Histo- and Cytopathology, Houten, The Netherlands

T. Nijsten

Erasmus MC Cancer Institute, Dermatology, Rotterdam, The Netherlands

L. Hollestein

Erasmus MC Cancer Institute, Dermatology, Rotterdam, The Netherlands; Netherlands Comprehensive Cancer Organization, Research and Development, Utrecht, The Netherlands